The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

Enolen is currently being studied in a Phase 1 trial evaluating its safety, tolerability and preliminary efficacy for localized sustained delivery of enzalutamide into the prostate. Alessa expects to ...

An experimental drug for advanced prostate cancer has shown preliminary success in the first and second phases of clinical trials, shrinking tumors in the lab and reducing signs of the disease in ...

Drug Used for Enlarged Prostate Tied to High Glaucoma Risk The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study ...

Giles Turner, from Brighton, is one of the men who could benefit from the drug Men with aggressive prostate cancer should be given a drug that halves their risk of death, experts have urged the NHS.

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...

NEW YORK (Reuters Health) - Men taking cholesterol-lowering medication may be less likely to get prostate cancer than those not on the drugs, suggests a new study. They are also less likely to wind up ...

Benign prostatic hyperplasia (BPH) and overactive bladder (OAB) syndrome are distinct health conditions but may cause similar symptoms, such as urgent or frequent urination. BPH is the noncancerous ...

Prostate medicines may decrease Lewy body dementia risk, a recent study says. Drugs terazosin, doxazosin, and alfuzosin relax the prostate and bladder muscles. Patients receiving these ...

Use of 5-α reductase inhibitors for benign prostatic hyperplasia (BPH) does not significantly increase the risk of hip fracture, researchers concluded in The Journal of the American Medical ...

WAYNE, Pa., July 14, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced results of a new survey showing that the majority of American men over age 40 are prescribed multiple ...